Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Genomic investigation reveals contaminated detergent as the source of an ESBL-producing Klebsiella michiganensis outbreak in a neonatal unit.

Chapman P, Forde BM, Roberts LW, Bergh H, Vesey D, Jennison AV, Moss S, Paterson DL, Beatson SA, Harris PNA.

J Clin Microbiol. 2020 Feb 26. pii: JCM.01980-19. doi: 10.1128/JCM.01980-19. [Epub ahead of print]

PMID:
32102855
2.

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei.

Roberts LW, Harris PNA, Forde BM, Ben Zakour NL, Catchpoole E, Stanton-Cook M, Phan MD, Sidjabat HE, Bergh H, Heney C, Gawthorne JA, Lipman J, Allworth A, Chan KG, Chong TM, Yin WF, Schembri MA, Paterson DL, Beatson SA.

Nat Commun. 2020 Jan 24;11(1):466. doi: 10.1038/s41467-019-14139-5.

3.

A hybrid simulation model approach to examine bacterial genome sequencing during a hospital outbreak.

Elliott TM, Lee XJ, Foeglein A, Harris PN, Gordon LG.

BMC Infect Dis. 2020 Jan 23;20(1):72. doi: 10.1186/s12879-019-4743-3.

4.

Bacterial Profile, Multi-Drug Resistance and Seasonality Following Lower Limb Orthopaedic Surgery in Tropical and Subtropical Australian Hospitals: An Epidemiological Cohort Study.

Vickers ML, Ballard EL, Harris PNA, Knibbs LD, Jaiprakash A, Dulhunty JM, Crawford RW, Parkinson B.

Int J Environ Res Public Health. 2020 Jan 20;17(2). pii: E657. doi: 10.3390/ijerph17020657.

5.

Erratum to 'When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit' [Clin Microbiol Infect 26 (1) (January 2020) 35-40].

Denny KJ, De Waele J, Laupland KB, Harris PNA, Lipman J.

Clin Microbiol Infect. 2020 Jan 20. pii: S1198-743X(20)30041-0. doi: 10.1016/j.cmi.2020.01.016. [Epub ahead of print] No abstract available.

PMID:
31968270
6.

Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of bla IMP-4 on an IncHI2 plasmid.

Roberts LW, Catchpoole E, Jennison AV, Bergh H, Hume A, Heney C, George N, Paterson DL, Schembri MA, Beatson SA, Harris PNA.

Microb Genom. 2020 Jan;6(1). doi: 10.1099/mgen.0.000321. Epub 2019 Dec 19.

7.

Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.

Paterson DL, Henderson A, Harris PNA.

Curr Opin Infect Dis. 2020 Feb;33(1):78-85. doi: 10.1097/QCO.0000000000000623.

PMID:
31834029
8.

Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections.

Stewart AG, Harris PNA, Chatfield M, Evans SR, van Duin D, Paterson DL.

Clin Infect Dis. 2019 Nov 18. pii: ciz1132. doi: 10.1093/cid/ciz1132. [Epub ahead of print]

PMID:
31738398
9.

Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study.

McNamara JF, Harris PNA, Chatfield MD, Lorenc P, Paterson DL.

Clin Microbiol Infect. 2020 Feb;26(2):257.e1-257.e4. doi: 10.1016/j.cmi.2019.10.011. Epub 2019 Oct 23.

PMID:
31654791
10.

Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia.

Fraser TA, Bell MG, Harris PNA, Bell SC, Bergh H, Nguyen TK, Kidd TJ, Nimmo GR, Sarovich DS, Price EP.

Microb Genom. 2019 Oct;5(10). doi: 10.1099/mgen.0.000307. Epub 2019 Oct 16.

11.

When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit.

Denny KJ, De Wale J, Laupland KB, Harris PNA, Lipman J.

Clin Microbiol Infect. 2020 Jan;26(1):35-40. doi: 10.1016/j.cmi.2019.07.007. Epub 2019 Jul 12. Review. Erratum in: Clin Microbiol Infect. 2020 Jan 20;:.

PMID:
31306790
12.

Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes.

Bordin A, Trembizki E, Windsor M, Wee R, Tan LY, Buckley C, Syrmis M, Bergh H, Cottrell K, Zowawi HM, Sidjabat HE, Harris PNA, Nimmo GR, Paterson DL, Whiley DM.

BMC Infect Dis. 2019 Jul 2;19(1):571. doi: 10.1186/s12879-019-4176-z.

13.

Health Risks of Flood Disasters.

Paterson DL, Wright H, Harris PNA.

Clin Infect Dis. 2018 Oct 15;67(9):1450-1454. doi: 10.1093/cid/ciy227. Review.

PMID:
30986298
14.

Association between higher ambient temperature and orthopaedic infection rates: a systematic review and meta-analysis.

Vickers ML, Pelecanos A, Tran M, Eriksson L, Assoum M, Harris PN, Jaiprakash A, Parkinson B, Dulhunty J, Crawford RW.

ANZ J Surg. 2019 Sep;89(9):1028-1034. doi: 10.1111/ans.15089. Epub 2019 Apr 11. Review.

PMID:
30974508
15.

Antimicrobial treatment challenges in the era of carbapenem resistance.

Peri AM, Doi Y, Potoski BA, Harris PNA, Paterson DL, Righi E.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):413-425. doi: 10.1016/j.diagmicrobio.2019.01.020. Epub 2019 Feb 5. Review.

PMID:
30905487
16.

By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?

Harris PNA.

Clin Infect Dis. 2019 Nov 27;69(12):2057-2058. doi: 10.1093/cid/ciz185. No abstract available.

PMID:
30839061
17.

Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-Reply.

Harris PNA, Tambyah P, Paterson DL.

JAMA. 2019 Feb 12;321(6):613. doi: 10.1001/jama.2018.19353. No abstract available.

PMID:
30747963
18.

Fosfomycin: what was old is new again.

Avent ML, Rogers BA, Cheng AC, Athan E, Francis JR, Roberts MJ, Paterson DL, Harris PNA.

Intern Med J. 2018 Dec;48(12):1425-1429. doi: 10.1111/imj.14122. No abstract available.

PMID:
30517987
19.

Infectious complications following transrectal ultrasound-guided prostate biopsy: what additional diagnostic value do blood cultures provide?

Sukumaran V, Roberts MJ, Harris PNA.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):804-806. doi: 10.1080/23744235.2018.1508886. Epub 2018 Oct 14. No abstract available.

PMID:
30317904
20.

Discovery of mcr-1-Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage.

Forde BM, Zowawi HM, Harris PNA, Roberts L, Ibrahim E, Shaikh N, Deshmukh A, Sid Ahmed MA, Al Maslamani M, Cottrell K, Trembizki E, Sundac L, Yu HH, Li J, Schembri MA, Whiley DM, Paterson DL, Beatson SA.

mSphere. 2018 Oct 10;3(5). pii: e00486-18. doi: 10.1128/mSphere.00486-18.

21.

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.

22.

Long-term morbidity and mortality following bloodstream infection: A systematic literature review.

McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL.

J Infect. 2018 Jul;77(1):1-8. doi: 10.1016/j.jinf.2018.03.005. Epub 2018 May 7.

PMID:
29746948
23.

The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.

Scott S, Harris PN, Williamson DA, Liss MA, Doi SAR, Roberts MJ.

World J Urol. 2018 Jul;36(7):1007-1017. doi: 10.1007/s00345-018-2217-7. Epub 2018 Feb 16.

PMID:
29453690
24.

Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.

Roberts MJ, Scott S, Harris PN, Naber K, Wagenlehner FME, Doi SAR.

World J Urol. 2018 Mar;36(3):323-330. doi: 10.1007/s00345-017-2163-9. Epub 2017 Dec 29. Review.

PMID:
29288398
25.

Melioidosis, Singapore, 2003-2014.

Pang L, Harris PNA, Seiler RL, Ooi PL, Cutter J, Goh KT, Cook AR, Fisher D, Chai LYA.

Emerg Infect Dis. 2018 Jan;24(1). doi: 10.3201/eid2401.161449.

26.

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.

Harris PNA, Ben Zakour NL, Roberts LW, Wailan AM, Zowawi HM, Tambyah PA, Lye DC, Jureen R, Lee TH, Yin M, Izharuddin E, Looke D, Runnegar N, Rogers B, Bhally H, Crowe A, Schembri MA, Beatson SA, Paterson DL; MERINO Trial investigators.

J Antimicrob Chemother. 2018 Mar 1;73(3):634-642. doi: 10.1093/jac/dkx466.

PMID:
29253152
27.

Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.

Djoko KY, Achard MES, Phan MD, Lo AW, Miraula M, Prombhul S, Hancock SJ, Peters KM, Sidjabat HE, Harris PN, Mitić N, Walsh TR, Anderson GJ, Shafer WM, Paterson DL, Schenk G, McEwan AG, Schembri MA.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02280-17. doi: 10.1128/AAC.02280-17. Print 2018 Feb.

28.

Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.

Harris PNA, Pezzani MD, Gutiérrez-Gutiérrez B, Viale P, Hsueh PR, Ruiz-Garbajosa P, Venditti M, Tumbarello M, Navarro-Francisco C, Calbo E, Akova M, Giamarellou H, Oliver A, Almirante B, Gasch O, Martínez-Martínez L, Schwaber MJ, Daikos G, Pitout J, Peña C, Hernández-Torres A, Doi Y, Pérez F, Tuon FF, Tacconelli E, Carmeli Y, Bonomo RA, Pascual Á, Paterson DL, Rodríguez-Baño J; ESGBIS/REIPI/INCREMENT Group.

Int J Antimicrob Agents. 2017 Nov;50(5):664-672. doi: 10.1016/j.ijantimicag.2017.08.005. Epub 2017 Aug 3.

PMID:
28782704
29.

Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.

Harris PNA, Peri AM, Pelecanos AM, Hughes CM, Paterson DL, Ferguson JK.

Antimicrob Resist Infect Control. 2017 Jan 21;6:14. doi: 10.1186/s13756-017-0177-0. eCollection 2017.

30.

Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, Wagenlehner FME.

Urology. 2017 Jun;104:11-21. doi: 10.1016/j.urology.2016.12.011. Epub 2016 Dec 19. Review.

PMID:
28007492
31.

Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.

Righi E, Peri AM, Harris PN, Wailan AM, Liborio M, Lane SW, Paterson DL.

J Antimicrob Chemother. 2017 Mar 1;72(3):668-677. doi: 10.1093/jac/dkw459. Review.

PMID:
27999023
32.

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.

Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodríguez-Baño J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SYC, Turnidge J, Utili R, Webb SAR, Paterson DL.

Clin Microbiol Infect. 2017 Aug;23(8):533-541. doi: 10.1016/j.cmi.2016.10.023. Epub 2016 Nov 1. Review.

33.

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.

Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, Lye DC.

PLoS One. 2016 Apr 22;11(4):e0153696. doi: 10.1371/journal.pone.0153696. eCollection 2016.

34.

An outbreak of scrub typhus in military personnel despite protocols for antibiotic prophylaxis: doxycycline resistance excluded by a quantitative PCR-based susceptibility assay.

Harris PNA, Oltvolgyi C, Islam A, Hussain-Yusuf H, Loewenthal MR, Vincent G, Stenos J, Graves S.

Microbes Infect. 2016 Jun;18(6):406-411. doi: 10.1016/j.micinf.2016.03.006. Epub 2016 Mar 19.

PMID:
27005452
35.

Colistin resistance: a major breach in our last line of defence.

Paterson DL, Harris PN.

Lancet Infect Dis. 2016 Feb;16(2):132-3. doi: 10.1016/S1473-3099(15)00463-6. Epub 2015 Nov 19. No abstract available.

PMID:
26603171
36.

Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.

Harris PN, Wei JY, Shen AW, Abdile AA, Paynter S, Huxley RR, Pandeya N, Doi Y, Huh K, O'Neal CS, Talbot TR, Paterson DL.

J Antimicrob Chemother. 2016 Feb;71(2):296-306. doi: 10.1093/jac/dkv346. Epub 2015 Nov 4. Review.

PMID:
26542304
37.

The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL.

Nat Rev Urol. 2015 Oct;12(10):570-84. doi: 10.1038/nrurol.2015.199. Epub 2015 Sep 1. Review.

PMID:
26334085
38.

Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.

Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN.

Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.

39.

Antiseptic Body Washes for Reducing the Transmission of Methicillin-Resistant Staphylococcus aureus: A Cluster Crossover Study.

Harris PN, Le BD, Tambyah P, Hsu LY, Pada S, Archuleta S, Salmon S, Mukhopadhyay A, Dillon J, Ware R, Fisher DA.

Open Forum Infect Dis. 2015 May 22;2(2):ofv051. doi: 10.1093/ofid/ofv051. eCollection 2015 Apr.

40.

Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice?

Harris PN, Alder L, Paterson DL.

Pathology. 2015 Jun;47(4):386-8. doi: 10.1097/PAT.0000000000000255. No abstract available.

PMID:
25938360
41.

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.

Harris PN, Yin M, Jureen R, Chew J, Ali J, Paynter S, Paterson DL, Tambyah PA.

Antimicrob Resist Infect Control. 2015 May 1;4:14. doi: 10.1186/s13756-015-0055-6. eCollection 2015.

42.

Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble.

Paterson DL, Harris PN.

Clin Infect Dis. 2015 Jul 15;61(2):155-6. doi: 10.1093/cid/civ227. Epub 2015 Mar 29. No abstract available.

PMID:
25824816
43.

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?

Harris PN, Tambyah PA, Paterson DL.

Lancet Infect Dis. 2015 Apr;15(4):475-85. doi: 10.1016/S1473-3099(14)70950-8. Epub 2015 Feb 23. Review.

PMID:
25716293
44.

Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymes.

Harris PN.

Semin Respir Crit Care Med. 2015 Feb;36(1):56-73. doi: 10.1055/s-0034-1398387. Epub 2015 Feb 2. Review.

PMID:
25643271
45.

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.

Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9.

46.

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults.

Harris PNA, Wang AD, Yin M, Lee CK, Archuleta S.

Lancet Infect Dis. 2014 Nov;14(11):1043. doi: 10.1016/S1473-3099(14)70976-4. Epub 2014 Oct 19. No abstract available.

PMID:
25444404
47.

Melioidosis: refining management of a tropical time bomb.

Fisher DA, Harris PN.

Lancet. 2014 Mar 1;383(9919):762-4. doi: 10.1016/S0140-6736(13)62143-1. Epub 2013 Nov 25. No abstract available.

48.

Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

Harris PN, Ferguson JK.

Int J Antimicrob Agents. 2012 Oct;40(4):297-305. doi: 10.1016/j.ijantimicag.2012.06.004. Epub 2012 Jul 21. Review.

PMID:
22824371
49.

Adhesive tape in the health care setting: another high-risk fomite?

Harris PN, Ashhurst-Smith C, Berenger SJ, Shoobert A, Ferguson JK.

Med J Aust. 2012 Jan 16;196(1):34. No abstract available.

PMID:
22256926
50.

Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay.

Harris PN, Williams NL, Morris JL, Ketheesan N, Norton RE.

Clin Vaccine Immunol. 2011 Aug;18(8):1288-91. doi: 10.1128/CVI.00077-11. Epub 2011 Jun 15.

Supplemental Content

Loading ...
Support Center